Psychiatry

Study shows risk intensifies with increasing duration of use, cumulative dose and average daily dose

Manufacturer has also filed for approval of lurasidone to treat bipolar depression in youth

But absolute risk small, so results should not be considered alarming, say researchers

Study examines effect of antidepressant switching vs augmentation therapy

But little evidence of positive effects on depression symptoms